JPS60190787A - Sialic acid derivative and its preparation - Google Patents

Sialic acid derivative and its preparation

Info

Publication number
JPS60190787A
JPS60190787A JP59044905A JP4490584A JPS60190787A JP S60190787 A JPS60190787 A JP S60190787A JP 59044905 A JP59044905 A JP 59044905A JP 4490584 A JP4490584 A JP 4490584A JP S60190787 A JPS60190787 A JP S60190787A
Authority
JP
Japan
Prior art keywords
group
sialic acid
acid derivative
benzyl
derivative according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59044905A
Other languages
Japanese (ja)
Other versions
JPH0534359B2 (en
Inventor
Tomoya Ogawa
智也 小川
Kazushige Fujikura
藤倉 一繁
Mamoru Sugimoto
守 杉本
Yoshiyasu Shidori
志鳥 善保
Masayoshi Ito
伊藤 正善
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANTO ISHI PHARMA CO Ltd
RIKEN Institute of Physical and Chemical Research
Original Assignee
KANTO ISHI PHARMA CO Ltd
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANTO ISHI PHARMA CO Ltd, RIKEN Institute of Physical and Chemical Research filed Critical KANTO ISHI PHARMA CO Ltd
Priority to JP59044905A priority Critical patent/JPS60190787A/en
Publication of JPS60190787A publication Critical patent/JPS60190787A/en
Publication of JPH0534359B2 publication Critical patent/JPH0534359B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound shown by the formula I (R1 is H, or CH3; R2 is acyl, or n-propyl; R3 and R4 are H, D-glucopyranosyl, 2,3,4-tri-O-benzyl-D-glycopyranosyl, 2,3,4-tri-O-benzyl-6-O-monochloroacetyl-D-glucopyranosyl, benzoyl, or benzyl; R5 and R6 are linked to form isopropylidene, or benzylidene; Ac is acetyl). USE:A remedy for meningitis. PREPARATION:A compound shown by the formula II is deacetylated, reacted with 2,2-dimethoxypropane to give a novel compound shown by formula III, which is reacted with a compound shown by the formula IV (X is halogen, Br is benzyl; MCA is monochloroacetyl) in a solvent such as 1,2-dichloroethane, etc. in the presence of glycosidation catalyst such as Hg(CH)2, etc. at -20-150 deg.C for 1-120hr, and if necessary, the protecting group is removed, or reduced, to give a compound shown by the formula I .

Description

【発明の詳細な説明】 本発明は、新規なシアル酸誘導体およびその製造法に関
する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel sialic acid derivative and a method for producing the same.

シアル酸を含む糖鎖は、糖蛋白、糖脂質、多糖系糖鎖な
どの部分構造を形成していることが知られている。それ
らの生物学上の機能としては、糖蛋白や細胞の寿命の決
定基や移々の關識缶白の受容部位としての機能などが、
種々解明されつつある。しかしながら、シアル酸を含む
オリゴ糖鎖を生物体から単離精製すること、およびこれ
を化学的に同定することは極めて困難である。したがっ
て、このようなシアル酸含有オリゴ糖鎖の精密合成は、
これら糖鎖の正確な生物IPr%iと分子措・造との相
関を解明するうえで必要不可欠なことである。
It is known that sugar chains containing sialic acid form partial structures such as glycoproteins, glycolipids, and polysaccharide sugar chains. Their biological functions include determining the lifespan of glycoproteins and cells, and acting as receptor sites for various biological functions.
Various things are being clarified. However, it is extremely difficult to isolate and purify oligosaccharide chains containing sialic acid from living organisms and to chemically identify them. Therefore, the precise synthesis of such sialic acid-containing oligosaccharide chains is
This is essential for elucidating the correlation between accurate biological IPr%i and molecular structure of these sugar chains.

本発明者らは、これまでにグルー7°Cメニンゴコツカ
ル多糖類の繰り返し構造のモデル糖脂aの合成に成功し
ているが(杉本、小川、日本農芸化学会昭和Sg年度大
会(79g 3 ) il/i演要旨集)、更にグルー
プYK属する糖類の合成研究を行い、本発明を完成する
に至った。
The present inventors have so far succeeded in synthesizing a model glycolipid a with a repeating structure of glue 7°C Meningokotsukal polysaccharide (Sugimoto, Ogawa, Japanese Agricultural Chemistry Society Showa Sg Annual Meeting (79g 3) il /i Abstracts), and further conducted research on the synthesis of saccharides belonging to Group YK, leading to the completion of the present invention.

本発明は、下記の一般式Iで表される新規なシアル酸誘
導体およびその製造法を提供するものである。
The present invention provides a novel sialic acid derivative represented by the following general formula I and a method for producing the same.

式中、R1は水素原子またはメチル基を示し、R2はア
リル基またはn−プロピル基を示し、R5およびR4は
それぞれ独立に1水素原子、D−グルコヒラノシル基、
2..1lI−ト1)−〇−ベンジルーo−yルコビラ
ノシル基、ユ、3.グートリー〇−ベンジル−6−〇−
モノクロルアセチルー〇−グルコピラノシル基、ベンゾ
イル基またはベンジル基を示し、R5およびR6はそれ
ぞれ水素原子を示すか、共同してインプロピリデン基ま
たはベンジリデン基を示し、Ac はアセチル基を示す
In the formula, R1 represents a hydrogen atom or a methyl group, R2 represents an allyl group or an n-propyl group, R5 and R4 each independently represent one hydrogen atom, a D-glucohyranosyl group,
2. .. 1lI-to1)-〇-benzyruo-ylucobyranosyl group, 3. Gutley〇-benzyl-6-〇-
It represents a monochloroacetyl-glucopyranosyl group, a benzoyl group or a benzyl group, R5 and R6 each represent a hydrogen atom or jointly represent an inpropylidene group or a benzylidene group, and Ac represents an acetyl group.

上記化合物はたとえば次のように合成することができる
The above compound can be synthesized, for example, as follows.

式(1): %式% (式中、Ac はアセチル基を示す) で表される化合物(]、)を脱アセチル化すると、式(
2)二OOH OOH で表される化合物(2)が得られる。これをa、2−ジ
メトキシプロパンと反応させることにより式(3):で
表される化合物(3)が得られる。
Formula (1): %Formula% (In the formula, Ac represents an acetyl group) When deacetylating the compound (], ), the formula (
2) Compound (2) represented by 2OOH OOH is obtained. Compound (3) represented by formula (3) is obtained by reacting this with a,2-dimethoxypropane.

また、上記一般式Iで表される化合物には、次の一般式
If、IIIおよび■で表される化合物が含まれる。
Further, the compounds represented by the above general formula I include compounds represented by the following general formulas If, III and ■.

\ORe 式中s R2はアリル基またはn−プ胃ビル基ヲ示し、
R5およびR6はそれぞれ水素原子を示すか、巷間して
インプロピリデン基を形成し、ACはアセチル基を示し
、R7は水素原子またはベンジル基を示し、R8は水素
原子またはモノクロルアセチル基を示す。
\ORe In the formula, s R2 represents an allyl group or an n-pyruyl group,
R5 and R6 each represent a hydrogen atom or together form an impropylidene group, AC represents an acetyl group, R7 represents a hydrogen atom or a benzyl group, and R8 represents a hydrogen atom or a monochloroacetyl group.

上記化合物は、式(3): (式中、Ac はアセチル基を示す) で表される化合物と、式(4): (式中、Xはハロゲン原子、Bn はベンジル基、MC
Aはモノクロルアセチル基を示す)で表される化合物(
4)を反応させ、必要により保訛基を還元または脱離す
ることにより合成することができる。
The above compound is a compound represented by formula (3): (wherein, Ac represents an acetyl group) and a compound represented by formula (4): (wherein, X is a halogen atom, Bn is a benzyl group, and MC
A represents a monochloroacetyl group)
It can be synthesized by reacting 4) and, if necessary, reducing or eliminating the anchor group.

さらに、上記一般式Iで表される化合物には、次の一般
式Vで表される化合物が含まれる。
Furthermore, the compound represented by the above general formula I includes a compound represented by the following general formula V.

式中、R7は水素原子またはメチル基を示し、R3およ
びR4はそれぞれ独立に、水屋原子、ベンジル基または
ベンゾイル基を示し、R5およびR6は共同してイソゾ
ロビリデン基またはベンジリデン基を示す。
In the formula, R7 represents a hydrogen atom or a methyl group, R3 and R4 each independently represent a Mizuya atom, a benzyl group or a benzoyl group, and R5 and R6 jointly represent an isozolopylidene group or a benzylidene group.

化合物(3)は、化合物m [Carbohydrat
e Re5ea−rch、7.!r(/9gO>/90
−/911.v。
Compound (3) is compound m [Carbohydrat
e Re5ea-rch, 7. ! r(/9gO>/90
-/911. v.

Eschenfelder & R,Brosmer]
 をアルコール等の溶媒中、ナトリウムメトキシドのよ
うな塩基を用いて脱アセチル化して化合物(2)を得、
これをDMF筈の溶媒中、p−)ルエンスルホン酸存在
下にコ。
Eschenfelder & R. Brosmer]
is deacetylated using a base such as sodium methoxide in a solvent such as alcohol to obtain compound (2),
This was mixed in a solvent supposed to be DMF in the presence of p-)luenesulfonic acid.

コージメトキップロノ′eンを加えて反応させることに
より合成できる。
It can be synthesized by adding kodimethoxyprone and reacting.

化合物(4)はたとえば次のように合成することがセき
る。まず、アリル−Ω、、?、1I−)ロー0−ベンジ
ルーβ−D−グルコピラノシドをピリジン中、モノクロ
ル酢酸無水物と反応させると6−〇−モノクロルアセチ
ル体が得られる。これを95%酢酸中、PdCl2. 
Na0Acで処理して脱アリル化したのち、5OC12
で処理すると目的のクロライド(4)が得られる。
Compound (4) can be synthesized, for example, as follows. First of all, Allyl-Ω...? , 1I-) When rho-0-benzyl-β-D-glucopyranoside is reacted with monochloroacetic anhydride in pyridine, a 6-0-monochloroacetyl compound is obtained. This was dissolved in 95% acetic acid with PdCl2.
After deallylation by treatment with Na0Ac, 5OC12
The desired chloride (4) can be obtained by treatment with .

本発明の、前記一般式0.lI[、IVで示される化金
物は、化合物(3)を糖受容体、化合物(4)を糖供与
体として両者を反応させ、必要により保護基を脱離また
は還元することにより得られる。
The general formula 0. The metal compound represented by lI[, IV can be obtained by reacting compound (3) with compound (3) as a sugar acceptor and compound (4) as a sugar donor, and removing or reducing the protecting group if necessary.

この反応は、ジクロロメタン、12−ジクロロエタン等
の溶媒中、Hf (CN ) 、HfB r 2 、モ
レキュラ一シーブス、At2GO6−ArClO41A
rO5O2CF3゜(CH3)3CO3O2CF3 等
のグリコシデージョン触媒存在下に、−20°c−is
o℃で/〜/2θ時間程度行えばよい。か(して得られ
る2糖(5)または(6)、または3糖(7)の保物基
を脱離または譚元することにより、それぞれ所望の化合
物を得ることができるO イソゾロビリデン基の脱離は、たとえば酢酸水溶液中、
30℃で、λ時間和度反応させること釦より行われる。
This reaction is carried out using Hf(CN), HfBr2, molecular sieves, At2GO6-ArClO41A in a solvent such as dichloromethane or 12-dichloroethane.
rO5O2CF3°(CH3)3CO3O2CF3 and other glycosidation catalysts at -20°C-is
It may be carried out at 0° C. for about 2θ hours. The desired compound can be obtained by removing or removing the preservation group of the disaccharide (5) or (6) or the trisaccharide (7) obtained by For example, in an acetic acid aqueous solution,
The reaction is carried out at 30° C. for λ time using the button.

モノクロルアセチル基は、メタノール等の溶媒中、ナ)
 IJウムメトキシド等の環部′を加えて、たとえば室
温で/時間和度処理することにより脱離する。
The monochloroacetyl group can be removed in a solvent such as methanol, etc.
A ring moiety such as IJ methoxide is added and removed by, for example, a softening treatment at room temperature for an hour.

アリル基の還元と脱ベンジル化は、たとえば、酢酸等の
溶媒中、Pd/c 存在下に接触還元することにより、
同時に進行する。
Reduction and debenzylation of the allyl group can be carried out, for example, by catalytic reduction in the presence of Pd/c in a solvent such as acetic acid.
proceed at the same time.

本発明の、前記一般式Vで表される化合物は、化合物(
3)を、ぎリジン中、ベンゾイルクロライドで処理すれ
ば化合物06)が、ピリジン中、ベンゾイルクロライド
およびN、N−ジメチルアミノピリジンで処理すれば化
合物(17)がそれぞれ得られる。また、化合物(2)
をたとえば、DMF −OH!lCN中、パラトルエン
スルホン酸存在下に、ベンズアルデヒドジメチルアセタ
ールで処理すれば、ベンジリデン体a81を得ることが
できる。さらにまた、化合物(181をピリジン/ベン
ゾイルクロライドで処理すると、ジベンゾイル休0翅が
得られる。
The compound represented by the general formula V of the present invention is a compound (
Compound 06) is obtained by treating 3) with benzoyl chloride in gyridine, and compound (17) is obtained by treating with benzoyl chloride and N,N-dimethylaminopyridine in pyridine. Also, compound (2)
For example, DMF -OH! By treating with benzaldehyde dimethyl acetal in the presence of para-toluenesulfonic acid in lCN, benzylidene compound a81 can be obtained. Furthermore, treatment of compound (181) with pyridine/benzoyl chloride provides dibenzoyl chloride.

一方、化合物(3)をDMF中、[3aO/ Ba(O
H)2存在下にベンジルブロマイドで処理すると化合物
f2i1 。
On the other hand, compound (3) was added to [3aO/Ba(O
H) Compound f2i1 upon treatment with benzyl bromide in the presence of 2.

(221が得られ、これをメタノール中、ジアゾメタン
等でエステル化すれば、それぞれ化合物(20および(
2:う)が得られる。
(221 was obtained, which was esterified with diazomethane etc. in methanol to give the compounds (20 and (
2: U) is obtained.

本発明化合物の合成経路の一例を次に示す。An example of the synthetic route for the compound of the present invention is shown below.

本発明の化合物は、髄膜炎菌の莢膜性多糖類の14造に
あるグルーfYに属するものであり、髄膜炎治療薬とし
て極めて有用である。
The compound of the present invention belongs to Glue fY, which is a 14-molecule capsular polysaccharide of Neisseria meningitidis, and is extremely useful as a therapeutic agent for meningitis.

本発明において得られる化合物(2)、(31、(5)
、(6)、(7)、 C8)、(9)、(【0)、(f
l!、αり、([3、αΦ、u5J、C6)、(17)
、f181 、μ功、(201,I2の、gaおよび□
□□はいずれも新規化合9勿である。
Compounds (2), (31, (5) obtained in the present invention)
, (6), (7), C8), (9), (0), (f
l! , αri, ([3, αΦ, u5J, C6), (17)
, f181, μgong, (201, I2's, ga and □
□□ are all new compounds 9.

以下、実施列を示し1本発明を更に具体的に説明する。Hereinafter, the present invention will be explained in more detail by showing examples.

実施例/ 化合物(11、?、θf (5,4O−1)をメタノー
ル3θ−に溶かし、2g%CH3ONa #液θ、2ゴ
を加え室温で2時間攪拌する。反応液をアンバーリスト
^−75で中和したのちろ過し、メタノールで針状晶 
/1f(91A6%)+ml)I2−410(吸傳性)
〔α絡5−3θ(c=lθveoH) 元素分析 計算値 C,1,3g 、Hr&7グ、N、
3.gt(015825NO9として) 枳11定f1自 C,グg、!;/ 、 H、ム71り
、N、J、’77R/ 0.k t (suoh−εt
oh−H2o 、2 : / : / )実施例コ 化合物(2136,3W9(/、θmmo l )をD
 MF g、θ、ff7!に溶かし、P−トルエンスル
ホンNf(/水和物)コ0岬を加え、8温で攪拌しなが
らユa−ジメトキシf四ノやン//弘η(Mw10!、
/j 、/、7mmo I )を加え1時間攪拌する。
Example/ Compound (11,?, θf (5,4O-1) is dissolved in methanol 3θ-, 2g% CH3ONa #solution θ, 2g is added and stirred at room temperature for 2 hours. The reaction solution is mixed with Amberlyst^-75 After neutralizing with
/1f (91A6%) + ml) I2-410 (absorptive)
[α connection 5-3θ (c=lθveoH) Elemental analysis Calculated value C, 1, 3g, Hr & 7g, N,
3. gt (as 015825NO9) 枳11fix f1业C, gg,! ;/ , H, MU71RI, N, J, '77R/ 0. k t (suoh−εt
oh-H2o, 2: /: /) Example co-compound (2136,3W9 (/, θmmol))
MF g, θ, ff7! P-toluenesulfone Nf (/hydrate) was added to the solution, and while stirring at 8 temperature, the mixture was dissolved in P-toluenesulfone Nf (Mw10!).
/j, /, 7mmo I) and stirred for 1 hour.

反応液にトリエチルアミン0./meを加え、減圧乾固
し、残渣を810□C−30θ tiotを用いフラッ
シュクロマトにて精製する。s%MeOH含有EtOA
eにより化合物43)を得る。
Add 0.0% triethylamine to the reaction solution. /me is added, dried under reduced pressure, and the residue is purified by flash chromatography using 810□C-30θ tiot. EtOA containing s% MeOH
Compound 43) is obtained by e.

針状結晶 33/mycg2%) mp/g3−4”元
素分析 計算値 C1左3.3g、H,7,,23xN
*’3.グア(C48829NO9トシテ) 測定値 C1左3.左7 H,7−,2g x + 3
1Lt3〔α)C3−2,30(C=i 0 MaOH
)R/ 0.32<!;%MeOH含有EtOAc)実
施例3 活性化したモレキュラーシープクへ21に、シアン化水
銀37グ■(/、2ダrrrnol)、臭化水銀41 
’l g m? (/、2 II rrrnol)、化
合物(3)、507〜(/、211 rrrnol)及
びジクロルエタン5−を加え、水冷攪拌下、化合物(4
) /、0 /乙V(八ざ乙nyno l )をジクロ
ルエタン/θ−に溶かした溶液をアルゴン零囲気下滴下
する。滴下終了後反応液を乙θ0で27時間加熱攪拌す
る。反応液をろ過し、ろ液をNaHCO3溶液及び飽和
食塩水で洗浄したのち、無水硫酸マグネシウムで乾燥後
減圧濃縮する(粗収量/、7 lI/ f )。
Needle-shaped crystals 33/mycg2%) mp/g3-4" Elemental analysis Calculated value C1 left 3.3g, H, 7,, 23xN
*'3. Gua (C48829NO9 Toshite) Measured value C1 left 3. Left 7H, 7-, 2g x + 3
1Lt3[α)C3-2,30(C=i0MaOH
)R/0.32<! ;% MeOH-containing EtOAc) Example 3 To the activated molecular sheep, 37 grams of mercury cyanide (/, 2 darrnol), 41 grams of mercury bromide
'l g m? (/, 2 II rrrnol), compound (3), 507~(/, 211 rrrnol), and dichloroethane 5- were added, and under stirring with water cooling, compound (4
) /, 0 / OtsuV (Yazaotsu nyno l ) dissolved in dichloroethane/θ- is added dropwise under an argon atmosphere. After completion of the dropwise addition, the reaction solution was heated and stirred at θ0 for 27 hours. The reaction solution is filtered, and the filtrate is washed with NaHCO3 solution and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure (crude yield/7 lI/f).

残渣を5ho2c −300CIθ1)を用いフラッシ
ュクロマトにより精製する。トルエン−酢酸エチル(グ
:/)及びトルエン−酢酸エチル(/:/)の混合溶媒
を用いることにより化合物(5)、229■(/ 3.
g%)、化合物(6)g6M? (7,4% )、化合
物(7)、279 Tn9(/ k、g % ) ヲ4
?、=。
The residue is purified by flash chromatography using 5ho2c-300CIθ1). Compound (5), 229■(/3.
g%), Compound (6) g6M? (7,4%), compound (7), 279 Tn9 (/k, g%) wo4
? ,=.

〔化合物(5)〕 元素分析 計算値 CA;9.、!;2.H,1,39
,N、il1g(C47H58NO15′2H20とし
て)測定値 C9タ9!’73.H,ム/9.N、13
4t〔α’]、+’13.3°(C=lθ/c+c/、
)R/ C33(トルエン−酢エチ/:/)〔化合物(
6)〕 元素分析 計算値 C2乙θ1s7rH,ム左0.N、
l!r/(C47HssNO+ 5Cl−H2Oとして
)測定値 C2乙θg51H1k3g、N、14を乙〔
α躇3+乙θ0(C=θ/3CHCIJ3)R/ 0.
/3Cトルエンー酢エチ /:/)〔化合物(力〕 元素分析 計算値 C+A弘、、l+++ム/7.N、
C9り(C76H87No2.C7!!2として)測定
値 C2乙弘07.Hrム/g、N、C99〔α〕乙3
+、l直C=10コ cHclx、)R/ θ乙g(ト
ルエン−酢エチ /:/)実施例グ 化合物(5) / 07 W (0,/ / 7 rr
mol)をAcOH:H2O1I:/の混合溶媒10艷
に溶かし、S0℃で2時間加熱攪拌する。反応終了後減
圧で溶媒を留去し、残渣をカラムクロマトにより精製す
る。トルエン−酢酸エチル/:2の混合溶媒によ−り化
合物(8)&7キ(5,t、A%)を得た。
[Compound (5)] Elemental analysis Calculated value CA; 9. ,! ;2. H,1,39
,N,il1g (as C47H58NO15'2H20) Measured value C9ta9! '73. H, Mu/9. N, 13
4t[α'], +'13.3° (C=lθ/c+c/,
)R/C33(Toluene-ethyl acetate/:/) [Compound (
6)] Elemental analysis Calculated value C2 θ1s7rH, MU 0. N,
l! r/(as C47HssNO+ 5Cl-H2O) Measured value C2 θg51H1k3g, N, 14 [
αH3+Otsuθ0 (C=θ/3CHCIJ3)R/ 0.
/3C toluene-ethyl acetate /:/) [Compound (force)] Elemental analysis Calculated value C+A Hiroshi,,l+++mu/7.N,
C9ri (as C76H87No2.C7!!2) Measured value C2 Otsuhiro 07. Hrm/g, N, C99 [α] Otsu 3
+, l direct C = 10 cHclx,) R/ θg (toluene-acetic acid ethyl alcohol /:/) Example compound (5) / 07 W (0, / / 7 rr
mol) was dissolved in a mixed solvent of AcOH:H2O1I:/, and heated and stirred at SO0C for 2 hours. After the reaction is completed, the solvent is distilled off under reduced pressure, and the residue is purified by column chromatography. Compound (8) & 7ki (5, t, A%) was obtained using a mixed solvent of toluene-ethyl acetate/:2.

元素分析 計算値 C2乙コ/2.H,L37.N、l
左3(C44H54NO4501−3AC7H8として
)測定値 C2乙コ、3!;*H*’7./A;、N、
13乙〔α絡”IIダ(c=θ左θ CHCl3)Rf
O,汐4t(クロロホルム:エタノール10:/)実施
例5 化合物(8) タ7キ(0,013mmo l )をメ
タノールlIコに溶かし、N −NaOCH3溶液0.
/ツを加えて室温で7時間攪拌する。反応液をアンバー
リストA−/&で中和し、樹脂を許去したのち、減圧濃
縮し、残渣をカラムクロマトにより分離精製する。
Elemental analysis Calculated value C2 Oko/2. H, L37. N,l
Left 3 (as C44H54NO4501-3AC7H8) Measured value C2 Otoko, 3! ;*H*'7. /A;,N,
13 Otsu [α connection” II da (c = θ left θ CHCl3) Rf
O, Shio 4t (Chloroform: Ethanol 10:/) Example 5 Compound (8) Ta7ki (0,013 mmol) was dissolved in methanol 1I, and N-NaOCH3 solution 0.
/ of the mixture and stirred at room temperature for 7 hours. After the reaction solution is neutralized with Amberlyst A-/& to remove the resin, it is concentrated under reduced pressure, and the residue is separated and purified by column chromatography.

5I02 /Q f 1りoロホルム:エタノール(2
θ二/)により化合物(9)、? g q(73,7%
)及び化合物00)q■(/ 7.3%)を得た。
5I02 /Q f 1 Rioroform: Ethanol (2
θ2/) gives compound (9), ? g q (73,7%
) and compound 00)q■ (/7.3%) were obtained.

〔化合物(9)〕 元素分析 計算値 C16/デf、H,ム7/、Nri
り6(C42H53N 014・H20として)測定値
 C16/6/、H1′7.θ2.N、177〔α〕乙
4+λコア(C=0.ム結 CHCA’5)Fl/ o
、l/locり眉ロホルム:エタノール/θ:/)〔化
合物(10) ) R/=a11.S−(クロロホルム:エタノール/θ:
/)実施例6 化合物(9134q(θ、θ41 j ryyno l
 )にAcOHjmlを加え、10%pd−C3gIn
gを加え、S0℃で30分接触還元する。反応終了後P
d−Cを沖去し、減圧乾固する。化合物α1) 2 ’
l mg(宇部的)が得られた。
[Compound (9)] Elemental analysis Calculated values C16/def, H, Mu7/, Nri
ri6 (as C42H53N 014/H20) Measured value C16/6/, H1'7. θ2. N, 177 [α] Otsu 4 + λ core (C = 0.mu CHCA'5) Fl/ o
, l/loc eyebrow loform: ethanol/θ:/) [Compound (10)) R/=a11. S-(chloroform:ethanol/θ:
/) Example 6 Compound (9134q(θ, θ41 j ryynol
) was added with AcOHjml and 10% pd-C3gIn
g and catalytic reduction at SO 0°C for 30 minutes. After the reaction
Remove d-C and dry under reduced pressure. Compound α1) 2'
1 mg (Ube) was obtained.

〔化合物α9〕 実施例7 化合物GO) 9.0〜(θ、θ/ / mmol)を
酢酸左meに溶かし、70%pd−CI3〜を加えgo
℃で3θ分接触還゛元する。ろ過してpd−Cを除き母
液を減圧乾固する。化合物(121乙、θ〜(定預的)
が得られた。
[Compound α9] Example 7 Compound GO) Dissolve 9.0~(θ, θ/ / mmol) in acetic acid, add 70% pd-CI3~ and go
Catalytic reduction was carried out at ℃ for 3θ minutes. Filter to remove pd-C, and dry the mother liquor under reduced pressure. Compound (121 Otsu, θ~ (depository)
was gotten.

〔化合物(121) 実施例g 化合物(7)9乙、9 my (0,06g rrrn
ol>にgO%AcOH溶液107!を加え、30℃で
2時間加熱攪拌する。反応終了後、溶媒を留去し、カラ
ムクロマトにて精製する。トルエン−酢酸エチル=/:
ユ混合溶媒により化合物a3)7乙++v(g O,7
%)を得た0 元素分析 計舞値 C1乙コ、6乙HH+ム/、21N
、lθ0(C73H8,No21C12・H20として
)測定値 C1乙コ、30 t H,ム07.N、θタ
グ〔α絡4+lIムff(c=θ、75.CHC〜)R
/ C32(トルエン−酢酸エチル=/:、5−)実施
例デ 化合物Q31 7 A 17g”、(0,0!; 5 
mmol)をメタノール1Irnlに溶かし、0.I 
N −NaOCH30,/ meを加え、室温にて77
時間攪拌する。アンバーリス)A−/左で中和したのち
ろ過し、減圧濃縮する。残渣をシリカビ/1/カラムク
ロマトにより精製する。化合物Iが37 rn9(!;
 l/L、g%)得られた。
[Compound (121) Example g Compound (7) 9 otsu, 9 my (0.06 g rrrn
ol>gO% AcOH solution 107! was added, and the mixture was heated and stirred at 30°C for 2 hours. After the reaction is completed, the solvent is distilled off and the product is purified by column chromatography. Toluene-ethyl acetate =/:
Compound a3) 7 O + + v (g O, 7
%) obtained 0 Elemental analysis Measurement value C1 Oko, 6 Otsu HH+mu/, 21N
, lθ0 (as C73H8, No21C12/H20) Measured value C1 Oko, 30 t H, Mu07. N, θ tag [α connection 4 + lIm ff (c = θ, 75.CHC ~) R
/ C32 (toluene-ethyl acetate =/:, 5-) Example De Compound Q31 7 A 17g", (0,0!; 5
mmol) in 1 Irnl of methanol. I
Add N-NaOCH30,/me to 77% at room temperature.
Stir for an hour. After neutralizing with Amberlis) A-/left, filter and concentrate under reduced pressure. The residue is purified by Silica/1/column chromatography. Compound I is 37 rn9 (!;
l/L, g%) was obtained.

元素分析 計算値 C,乙ぷ5グl Hl乙7ざ、N、
l//(C/19H81N019・ユH20として)測
定値 C2乙左乙7.H1乙j、2.N、z4/4’〔
α絡1+グ、L、t(C−θ、コざ5 cHcd3)R
f θ乙0(クロロホルム:エタノール10 : / 
)実施例10 化合物(14127m? (0,022mmol)に酢
酸5 m/を加え、10%Pd−C,27哩を加え、g
o℃で3θ分接触遣元する。反応液をろ過し、Pd−C
を除き母液を減圧乾固する。化合物05)が/ ’1.
g■(定量的)得られた。
Elemental analysis Calculated value C, Otsu 5gl Hl Otsu 7za, N,
l//(as C/19H81N019/YH20) Measured value C2 Otsusa Otsu7. H1 otsu j, 2. N, z4/4' [
α connection 1 + G, L, t (C-θ, Koza 5 cHcd3) R
f θ Otsu 0 (Chloroform: Ethanol 10: /
) Example 10 To the compound (14127 m? (0,022 mmol), add 5 m/l of acetic acid, add 27 m/l of 10% Pd-C, and add g
Contact was carried out for 3θ minutes at 0°C. The reaction solution was filtered and Pd-C
The mother liquor is dried under reduced pressure. Compound 05) is / '1.
g■ (quantitative) obtained.

R/ 0.113 (BuOH:EtOH:H2O2:
 / : / )実施例// 化合物(3)乙lI左キ(7,1面Ql)をピリジン/
コ一に溶かし、ベンゾイルクロ2イド673■を加え室
温で一昼夜攪拌する。反応液を減圧濃縮したのち、酢酸
エチルエステル及びH2Oを加えて振とうする。酢酸エ
チル層を硫酸マグネシウムで乾燥したのち、減圧濃縮し
、残渣をシリカゲルC−3θθ 7θ?を用いて精製す
る。トルエン−酢酸エチル/:/混合溶媒により化合物
σ61’7/9■(73,!;%)が得られた。
R/ 0.113 (BuOH:EtOH:H2O2:
/ : / )Example// Compound (3) OtsulI left key (7, 1st side Ql) with pyridine/
Dissolve the mixture in a pot, add 673 cm of benzoyl chloride, and stir at room temperature overnight. After the reaction solution was concentrated under reduced pressure, ethyl acetate and H2O were added and shaken. After drying the ethyl acetate layer over magnesium sulfate, it was concentrated under reduced pressure, and the residue was purified with silica gel C-3θθ 7θ? Purify using. Compound σ61'7/9 (73,!;%) was obtained using a toluene-ethyl acetate/:/ mixed solvent.

針具 mpgO〜g−〇 元素分析 計算値 C1乙7011 、 H、ム曙’ 
r N+ −2,−22(03□H57NO71・H2
Oとして)測定値 C1乙i27 、 H、ム乙6.N
、2.AOcα)P ’ −119,110(C==i
00 、 cHc6a)R/ θl、、/ (EtOA
c) 実施例/、2 化合物f3) ’f’ 0 ”9 (0,/ mmol
)をとりピリジン/、θゴに溶かし、N、N−ジメチル
アミノピリジン/2rmi及びベンゾイルクロライド5
6■を加え室温で一昼夜攪拌する。反応液を減圧濃縮し
、残渣を酢酸エチルエステルに溶かし、飽和重そう水、
飽和食塩水で洗浄する。無水硫酸マグネシウムで乾燥し
たのち減圧濃縮し、残渣をシリカゲルC−30010t
を用いて精製する。トルエン−酢酸エチル/:/の混合
溶媒により化合物tn)3s〜を得る( 37.7%)
Needle tool mpgO~g-〇Elemental analysis Calculated value C1 Otsu 7011, H, Mu Akebono'
r N+ -2, -22 (03□H57NO71・H2
O) Measured value C1 Oi27, H, Mu Otsu6. N
, 2. AOcα)P' -119,110(C==i
00, cHc6a)R/θl,,/(EtOA
c) Example/, 2 Compound f3) 'f' 0 "9 (0,/ mmol
) was dissolved in pyridine/, θ, N,N-dimethylaminopyridine/2rmi and benzoyl chloride 5
6) and stirred at room temperature overnight. The reaction solution was concentrated under reduced pressure, the residue was dissolved in ethyl acetate, and saturated deuterated water,
Wash with saturated saline. After drying over anhydrous magnesium sulfate, it was concentrated under reduced pressure, and the residue was purified with silica gel C-30010t.
Purify using. Compound tn) 3s~ is obtained using a mixed solvent of toluene-ethyl acetate/:/ (37.7%)
.

元素分析 !f算値 C,A2.gll、H,ム/(7
,N、コλデ(052H57No11 として) 測定値 C1乙2.93.H,ム/3.N、、2.15
〔α〕♂” +’72°(C−θSダCHCl3)実施
例/3 化合物(2)3乙JTng(/、θrrmo l )を
DMF−CH5CN(/ : / )、tmlに溶かし
、パラトルエンスルホン酸/水塩2θ〜、ベンズアルデ
ヒド ジメチルアセタール/67■を加え室温でg時間
攪拌する。反応液にトリエチルアミンθ、/−を加え減
圧濃縮する。残渣をシリカブ/l/ C−3θθ lθ
9を用いて精製する。3%メタノール含有酢酸エチルで
溶離することにより化合物θ(へ)236■を得る(左
2.3%)。
Elemental analysis! f calculation value C, A2. gll, H, mu/(7
, N, code (as 052H57No11) Measured value C1 Otsu 2.93. H, Mu/3. N,,2.15
[α]♂''+'72° (C-θSdaCHCl3) Example/3 Compound (2) 3OJTng (/, θrrmol) was dissolved in DMF-CH5CN (/:/), tml, and para-toluenesulfone was added. Add acid/hydrate 2θ~ and benzaldehyde dimethyl acetal/67μ and stir at room temperature for g hours. Add triethylamine θ,/- to the reaction solution and concentrate under reduced pressure. Add silica/l/C-3θθ lθ to the residue.
Purify using 9. Elution with ethyl acetate containing 3% methanol yields compound θ(he)236■ (2.3% on the left).

R/ C3弘(5%メタノール含有酢酸エチル)実施例
/q 化合物α8) g !; m? (θ、/ g g m
mol)をピリジン0:3艷に溶かし、ベンゾイル ク
ロライド79rrvを加え室温で一昼夜攪拌する。反応
液を酢酸エチルエステルに溶かし、水洗する。無水硫敵
マグネシウムで乾燥したのち減圧濃縮し、残渣をシリカ
/r′ルカラムにて精製する。化合物α97/fflF
(5g、4%)が看られた。
R/ C3 Hiro (ethyl acetate containing 5% methanol) Example/q Compound α8) g! ; m? (θ, / g g m
Dissolve mol) in 0:3 pyridine, add 79rrv of benzoyl chloride, and stir at room temperature overnight. Dissolve the reaction solution in ethyl acetate and wash with water. After drying over anhydrous magnesium sulfate, it was concentrated under reduced pressure, and the residue was purified using a silica/r' column. Compound α97/fflF
(5g, 4%) was observed.

実施例/5 BaQ 、2.621及びBa(OH)2・gH207
11,9mvをDMF5ml!に溶かし、化合物(3)
20 / rvy (0,0jmmol)、ベンジルブ
ロマイド/、g 3 fを加えて一昼夜攪拌する。反応
液にクロロホルム10θmlを加えて水洗する。クロロ
ホルム層を無水硫酸マグネシウムで乾燥し減圧濃縮する
。残渣をエーテルに溶かし、NaHCO3溶液で抽出す
る。N aHCO3層を希HCl溶液で弱酸性としてク
ロロホルムで抽出する。飽和食塩水で洗浄する。無水硫
酸マグネシウムで乾燥し減圧濃縮する。化合物(社)/
 911trngが得ら゛れる。これをメタノール3 
mlVに溶かし、・ジアゾメタンのエーテル溶液を加え
る。反応液を減圧濃縮し、残渣をシリカゲルカラムC−
300/θtを用いて精製する。トルエン−酢酸エチル
=/:/混合溶媒により化合物(21)/7乙■をイ↓
Fる( 40.3%)。
Example/5 BaQ, 2.621 and Ba(OH)2・gH207
11.9 mv in 5 ml of DMF! Dissolve compound (3) in
20/rvy (0.0 jmmol), benzyl bromide/g 3 f were added and stirred overnight. Add 10θml of chloroform to the reaction solution and wash with water. The chloroform layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue is dissolved in ether and extracted with NaHCO3 solution. The NaHCO3 layer is slightly acidified with dilute HCl solution and extracted with chloroform. Wash with saturated saline. Dry over anhydrous magnesium sulfate and concentrate under reduced pressure. Compound (company)/
911trng is obtained. Add this to 3 methanol
mlV and add an ethereal solution of diazomethane. The reaction solution was concentrated under reduced pressure, and the residue was transferred to a silica gel column C-
Purify using 300/θt. Compound (21)/7 with toluene-ethyl acetate =/:/ mixed solvent ↓
Furu (40.3%).

mp /37−9゜ 〔α酩6−/θケ0(C=12ユ c)lc6g)元素
分析 計算値 C2乙りgk、H,7,θ&、N、、2
グ0(C32H,1No9として) 世11定値 C1乙り乙グ、H,7,0グ2国、λ汐グ
Rf O,11,:l(トルエン−酢酸エチル/:/)
水層を希HC4で中和して弱酸性として、クロロホルム
/50m1で抽出する。飽和食塩水で流汗したのち、無
水硫酸マグネシウムで乾燥する。減圧濃縮し、残渣〔化
合物(22+ 1をメタノール5づに溶かし、ジアゾメ
タンのエーテルだ液を加える。反応液を減圧0縮し、残
渣をシリカゲルカラムC−300/θVを用いて精製す
る。トルエン−酢酸エチル=/:/混合溶媒姉より化合
物(23i 3 !r〜を得る(/ll−%)。
mp /37-9゜ [α酩6-/θke0 (C=12yu c) lc6g) Elemental analysis Calculated value C2 otori gk, H, 7, θ&, N,, 2
0 (as C32H, 1No9) World 11 constant value C1 Otori Otugu, H, 7, 0g 2 countries, λ Shiogu Rf O, 11, :l (Toluene-ethyl acetate/:/)
The aqueous layer is neutralized with dilute HC4 to make it slightly acidic and extracted with chloroform/50ml. After sweating with saturated saline solution, dry with anhydrous magnesium sulfate. Concentrate under reduced pressure, and the residue [Compound (22+1) is dissolved in 5 portions of methanol, and an ethereal solution of diazomethane is added. The reaction solution is concentrated under reduced pressure, and the residue is purified using a silica gel column C-300/θV.Toluene- A compound (23i 3 !r~ is obtained from ethyl acetate=/:/mixed solvent (/ll-%).

mp /、2グー6゜ 〔α〕δ6/lAグ’ CHc#6c =0.7 g元
素分析 計算値 C2乙θgグr Hr 7/汐、N、
2gグ(C25835NO9として) 測定値 C,61O/、H,7/グl N 12g4t
R/ 0.33<トルエン−酢酸エチル/:/)昭和 
年 月 日 1、事件の表示 11i、i和59年肪許願第449t
l15号2発明の名称 ンアル酸誘導体およびその製造
法3袖正をする者 事件との関係 出叩人 名称 (67!])理化学研究所 同 関東医師製薬株式会社 4代理人 (1勺石」し叉史7よし)
mp /, 2 goo 6゜[α]δ6/lAg'CHc#6c =0.7 g Elemental analysis Calculated value C2 θg gr Hr 7/shio, N,
2g (as C25835NO9) Measured value C,61O/, H,7/Gl N 12g4t
R/ 0.33<Toluene-ethyl acetate/:/) Showa
Year, month, day 1, case display 11i, i Japanese 59 year patent application No. 449t
No. 15 No. 2 Name of the invention Alkaline acid derivatives and their manufacturing method 3 Relationship with the case of person who tampered with the issue Name of person (67!) RIKEN Kanto Ishiba Pharmaceutical Co., Ltd. 4 Representative (1 Hoseki) History 7)

Claims (1)

【特許請求の範囲】 (1) 下記の一般式lで表されるシアル酸誘導体。 式中、R4は水素原子またはメチル基を示し、R2はア
リル基またはn−グロビル基を示し、RおよびR4はそ
れぞれ独立に、水素原子、D一グルコビラノシル基、2
.3.’l−トリーO−ベンジルーD−グルコピラノシ
ルa、2.3.?−トリー0−ベンジルー6−0−モノ
クロルアセチル−D−グルコピラノシル基、ベンゾイル
基またはベンジル基を示し、R5およびR6はそれぞれ
水素原子を示すか、共同してインプロピリデン基または
ベンジリデン基を示し、 Ac はアセチル基を示す。 T2) R,がメチル基、R2がアリル基、R3,R4
tRおよびR6が水素原子である特許請求の範門弟7項
記載のシアル酸誘導体。 (31R1がメチル基、 R2がアリル基、R3および
R4が水素原子、R5およびR6が共同してイソプロピ
リデン基である特許請求の範囲第1項記載のシアル酸誘
導体。 (4) R,がメチル基、R2がアリル基、R3がλ。 3、4t−トリー〇−ベンジルー乙−)モノクロルアセ
チル−D−グルコピラノシルl;、R4が水素原子、R
およびR6が共同してイソプロビリデン基である特許請
求の範囲第1項記載のシアル酸誘導体。 (5) R,がメチル基、R2がアリル基、R3が水素
原子、R4が、2.3. ll−トリー〇−ベンジルー
乙−〇−モノクロルアセチル−〇−グルコピラノシル基
、R5およびR6が共同してインプロピリデン基である
特許請求の範囲第1項記載のシアル酸誘導体。 (6) R4がメチル基、R2がアリル基、R6および
R4がそれぞれ、2,3.’l−トリー〇−ベンジルー
6−〇−モノクロルアセチル−α−D−グルコピラノシ
ル基、R5およびR6が共同してイソプロピリデン基で
ある特許請求の範囲第1−項記載のシアル酸誘導体。 (7) R1がメチル基、R2がアリル基、R3が2゜
3、 ’I−トリー〇−ベンジルー乙−〇−モノクロル
アセチル−〇−グルコピラノシル基、R4゜RおよびR
6が水素原子である特許請求の範囲第1項記載のシアル
酸誘導体。 (8) R,がメチル基、R2がアリル基、R5がユ3
、’l−トリーO−ベンジルーα−D−グルコピラノシ
ル基であり% R4’ R5およびR6が水素原子であ
る特許請求の範囲第1項記載のシアル酸誘導体。 (91R,がメチル基、R2がアリル基、R3がコ。 3、 ’I−トリー〇−ベンジルーβ−D−グルコピラ
ノシル基であり、R,RおよびR6が水素5 4+で、ある特許請求の範囲第1項記載のシアル酸誘導
体。 α[1)R4がメチル基、R2がn−プロピル基、R3
がα−D−グルコピラノシル基、R4,R5およびR6
が水素原子である特許請求の範囲第1項記載のシアル−
酸誘導体。 +it+ R4がメチル基、R2がn−プロピリデン、
R3がβ−〇−グルコピラノシル基、 R4+ R5お
よびR6が水素原子である特許請求の範囲第1項記載の
シアル酸誘導体。 02R4がメチル基、R2がアリル基、R3およびR4
がそれぞれ、2,3,4’−)ジ−0−ベンジル−6−
〇−モノクロルアセチル−α−D−グルコピラノシル某
、RおよびR6が水素原子である特許請求の範囲第1項
記載のシアル酸誘導体。 (131R1がメチル基、R2がアリル基、R3および
R4がそれぞれ、コ、、?、1I−)リーO−ベンジル
ーα−D−グルコピラノシル基、R5およびR6が水素
原子である特許請求の範囲第1項記載のシアル酸誘導体
。 R41R,がメチル基、R2がn−プロピル基、R3お
よびR4がそれぞれ、α−D−グルコピラノシル基、R
5およびR6が水素原子である特許請求の範囲第1項記
載のシアル酸誘導体。 α5) R,がメチル基、R2がアリル基、[(6がベ
ンゾイル基、Rが水素原子、R5およびR6が共同して
イソプロピリデン基である特許請求の範囲第1項記載の
シアル酸誘導体。 (+6) R,がメチル基、R2がアリル基、R3およ
びRがベンゾイル基、R5およびR6が共同してイソプ
ロピリデン基である特許請求の範囲第1項記載のシアル
酸誘導体。 0η R1がメチル基%R2がアリル基、R3およびR
4が水素原子、 R5およびR6が共同してベンジリデ
ン基である特許請求の範囲第1項記載のシアル酸誘導体
。 (181Rがメチル基、R2がアリル基、R3およびR
がベンゾイル基、R5およびR6が共同してベンジリデ
ン基である特許請求の範囲第1項記載のシアル酸誘導体
。 α!1R5が水素原子、R2がアリル基、R3およびR
4がベンジル基、R5およびR6が共同してインプロピ
リデン基である特許請求の範囲第1項記載のシアル酸誘
導体。 (2υ R1がメチル基%R2がアリル基、R3および
R4がベンジル基、R5およびR6が共同してインゾロ
ビリデン基である特許請求の範囲第1項記載のシアル酸
誘導体。 (21) R,が水素原子、R2がアリル基、R6がベ
ンジル基、R4が水素原子、R5およびR6が共同して
インプロピリデン基である特許請求の範囲第1項記載の
シアル酸誘導体。 (23R,がメチル基、R2がアリル基、R3がベンジ
ル基、R4が水素原子、R5およびR6が共同してイン
プロピリデン基である特許請求の範囲第1項記載のシア
ル酸誘導体。 (ハ)式(1): (式中、ACはアセチル基を示す) で表される化合物(1)を脱アセチル化して式(2):
で表される化合物(2)を得、これを2.2−ジメトキ
シプ四パンと反応させることを特徴とする、式(3): で表されるシアル酸誘導体の製造法。 (2を 式(3): (式中、Ac はアセチル基を示す) で表される化合物と、式(4): (式中、Xはハロゲン原子、Bn はベンジル基1MC
Aはモノクロルアセチル基を示す)で表される化合物(
4)を反応させ、必要により保護基を還元または脱離す
ることを特徴とする、下記の一般式で表されるシアル酢
゛誘導体の製造法。 式中、R4はメチル基、R2はアリル基またはn−プロ
ピル基、R3およびR4はそれぞれ独立に、水素原子、
D−グルコピラノシル基、223、 ’I−トリー〇−
ベンジルーD−グルコピラノフル基、またはコ、3.グ
ートリー〇−ベンジル−9−0−モノクロルアセチル−
D−グルコピラノシル基を示し、ただしR3およびR4
がP、1時二水素原子を示すことはなく、R5およびR
6はそれぞれ水素原子を示すか、共同してインゾロビリ
デン基を示す。
[Claims] (1) A sialic acid derivative represented by the following general formula 1. In the formula, R4 represents a hydrogen atom or a methyl group, R2 represents an allyl group or an n-globyl group, and R and R4 each independently represent a hydrogen atom, a D-glucobylanosyl group, 2
.. 3. 'l-tri-O-benzy-D-glucopyranosyl a, 2.3. ? -tri-0-benzy-6-0-monochloroacetyl-D-glucopyranosyl group, benzoyl group or benzyl group, R5 and R6 each represent a hydrogen atom or jointly represent an inpropylidene group or benzylidene group, Ac indicates an acetyl group. T2) R is a methyl group, R2 is an allyl group, R3, R4
The sialic acid derivative according to claim 7, wherein tR and R6 are hydrogen atoms. (The sialic acid derivative according to claim 1, wherein R1 is a methyl group, R2 is an allyl group, R3 and R4 are hydrogen atoms, and R5 and R6 are jointly an isopropylidene group. (4) R is methyl group, R2 is an allyl group, R3 is λ; 3,4t-tri-benzyl-)monochloroacetyl-D-glucopyranosyl;, R4 is a hydrogen atom, R
The sialic acid derivative according to claim 1, wherein R6 and R6 together represent an isopropylidene group. (5) R is a methyl group, R2 is an allyl group, R3 is a hydrogen atom, and R4 is 2.3. 2. The sialic acid derivative according to claim 1, wherein the ll-tri-benzyl-o-monochloroacetyl-o-glucopyranosyl group, R5 and R6 are jointly an inpropylidene group. (6) R4 is a methyl group, R2 is an allyl group, R6 and R4 are each 2, 3. The sialic acid derivative according to claim 1, wherein the 'l-tri-benzyl-6-o-monochloroacetyl-α-D-glucopyranosyl group, R5 and R6 are jointly an isopropylidene group. (7) R1 is a methyl group, R2 is an allyl group, R3 is 2゜3, 'I-tri〇-benzyl-〇-monochloroacetyl-〇-glucopyranosyl group, R4゜R and R
The sialic acid derivative according to claim 1, wherein 6 is a hydrogen atom. (8) R is a methyl group, R2 is an allyl group, and R5 is a
, 'l-tri-O-benzyl-α-D-glucopyranosyl group, and % R4' R5 and R6 are hydrogen atoms, the sialic acid derivative according to claim 1. (91R, is a methyl group, R2 is an allyl group, R3 is a co. The sialic acid derivative according to item 1. α[1] R4 is a methyl group, R2 is an n-propyl group, R3
are α-D-glucopyranosyl groups, R4, R5 and R6
sial according to claim 1, wherein is a hydrogen atom.
Acid derivatives. +it+ R4 is a methyl group, R2 is n-propylidene,
The sialic acid derivative according to claim 1, wherein R3 is a β-0-glucopyranosyl group, and R4+ R5 and R6 are hydrogen atoms. 02R4 is a methyl group, R2 is an allyl group, R3 and R4
are respectively 2,3,4'-)di-0-benzyl-6-
The sialic acid derivative according to claim 1, wherein 0-monochloroacetyl-α-D-glucopyranosyl, R and R6 are hydrogen atoms. (131R1 is a methyl group, R2 is an allyl group, R3 and R4 are each a co, ?, 1I-) Lee O-benzyl-α-D-glucopyranosyl group, and R5 and R6 are hydrogen atoms Claim 1 Sialic acid derivatives described in Section. R41R, is a methyl group, R2 is an n-propyl group, R3 and R4 are α-D-glucopyranosyl groups, R
The sialic acid derivative according to claim 1, wherein 5 and R6 are hydrogen atoms. α5) The sialic acid derivative according to claim 1, wherein R is a methyl group, R2 is an allyl group, [(6 is a benzoyl group, R is a hydrogen atom, and R5 and R6 are jointly an isopropylidene group). (+6) The sialic acid derivative according to claim 1, wherein R is a methyl group, R2 is an allyl group, R3 and R are a benzoyl group, and R5 and R6 are jointly an isopropylidene group. 0η R1 is methyl The group %R2 is an allyl group, R3 and R
4. The sialic acid derivative according to claim 1, wherein 4 is a hydrogen atom, and R5 and R6 jointly represent a benzylidene group. (181R is a methyl group, R2 is an allyl group, R3 and R
The sialic acid derivative according to claim 1, wherein is a benzoyl group, and R5 and R6 are jointly a benzylidene group. α! 1R5 is a hydrogen atom, R2 is an allyl group, R3 and R
4. The sialic acid derivative according to claim 1, wherein 4 is a benzyl group, and R5 and R6 are jointly an inpropylidene group. (2υ The sialic acid derivative according to claim 1, wherein R1 is a methyl group, R2 is an allyl group, R3 and R4 are a benzyl group, and R5 and R6 are jointly an inzolobylidene group. (21) R is hydrogen The sialic acid derivative according to claim 1, wherein R2 is an allyl group, R6 is a benzyl group, R4 is a hydrogen atom, and R5 and R6 are jointly an inpropylidene group. (23R is a methyl group, The sialic acid derivative according to claim 1, wherein R2 is an allyl group, R3 is a benzyl group, R4 is a hydrogen atom, and R5 and R6 are jointly an inpropylidene group. (c) Formula (1): In the formula, AC represents an acetyl group) Compound (1) represented by the following is deacetylated to obtain the formula (2):
A method for producing a sialic acid derivative represented by the formula (3), which comprises obtaining a compound (2) represented by the formula and reacting the compound with 2,2-dimethoxyptetrapane. A compound represented by the formula (3): (wherein, Ac represents an acetyl group) and a compound represented by the formula (4): (wherein, X is a halogen atom, and Bn is a benzyl group)
A represents a monochloroacetyl group)
4) and, if necessary, reducing or eliminating the protective group, a method for producing a sialic acid derivative represented by the following general formula. In the formula, R4 is a methyl group, R2 is an allyl group or n-propyl group, R3 and R4 are each independently a hydrogen atom,
D-glucopyranosyl group, 223, 'I-tree〇-
Benzyl-D-glucopyranofur group, or co, 3. Gootry〇-benzyl-9-0-monochloroacetyl-
represents a D-glucopyranosyl group, where R3 and R4
does not represent a dihydrogen atom, and R5 and R
6 each represents a hydrogen atom, or together represent an inzolobylidene group.
JP59044905A 1984-03-09 1984-03-09 Sialic acid derivative and its preparation Granted JPS60190787A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59044905A JPS60190787A (en) 1984-03-09 1984-03-09 Sialic acid derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59044905A JPS60190787A (en) 1984-03-09 1984-03-09 Sialic acid derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS60190787A true JPS60190787A (en) 1985-09-28
JPH0534359B2 JPH0534359B2 (en) 1993-05-21

Family

ID=12704480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59044905A Granted JPS60190787A (en) 1984-03-09 1984-03-09 Sialic acid derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS60190787A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6314792A (en) * 1986-07-04 1988-01-21 Rikagaku Kenkyusho Neuacalpha-9neuac sugar donor and production thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6314792A (en) * 1986-07-04 1988-01-21 Rikagaku Kenkyusho Neuacalpha-9neuac sugar donor and production thereof
JPH07107074B2 (en) * 1986-07-04 1995-11-15 理化学研究所 NeuAcα2 → 9 NeuAc sugar donor

Also Published As

Publication number Publication date
JPH0534359B2 (en) 1993-05-21

Similar Documents

Publication Publication Date Title
US3994966A (en) Chelating agents
JPH0313240B2 (en)
JPS6345293A (en) Sialosylceramide compound and production thereof
JPH01156995A (en) Novel androstan-17-carboxylic ester, its production and medicine containing the same
JPS60190787A (en) Sialic acid derivative and its preparation
JPS60123494A (en) Sialic acid-containing oligosaccharide and its preparation
CA1320720C (en) Sialosyl glyceride and process for producing the same
JPS6112695A (en) Sialic acid derivative
US3585186A (en) Preparation of glycopyranosiduronides and glycopyranosides and products resulting therefrom
PT93799A (en) PROCESS FOR THE PREPARATION OF ETOPOSIDOS
JPS6391396A (en) Production of erythromycin a derivative
Shasha et al. Reactions of 1, 2-O-Isopropylidene-α-D-glucofuranose 5, 6-Thionocarbonate and Some Related Compounds1a
JPS6341493A (en) Ganglioside gm2-related compound and production thereof
JPS6045587A (en) Novel oligomannoside and its preparation
US3366666A (en) 6-bromo-3, 4-dihydroxyphenylalanines
US3449321A (en) Estrogen water-soluble 16alpha-yl-glucopyranosiduronic compounds and preparation thereof
US3308137A (en) Cyclopropa-androstenone compounds
JPH09249683A (en) N-actyl-d-neuraminic acid derivaitive and its production
JP5258261B2 (en) Labeled glycyrrhetinic acid and its derivatives
JPH01100147A (en) Optically active malonic acid ester derivative
JPS6314793A (en) Neuacalpha2-6galbeta1-4glcbeta1-ceramide and production thereof
JPS63222192A (en) Novel ganglioside-related compound and production thereof
JPS6094989A (en) Novel trisaccharide compound and its preparation
JPS5919555B2 (en) Nitrosourea transparent conductor and its manufacturing method
JPH0616667A (en) New production of pyrazolo(1,5-a)pyridine derivative